Kupchan et al., 1978 - Google Patents
Tumor inhibitors. 124. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoidsKupchan et al., 1978
- Document ID
- 4449706727200449415
- Author
- Kupchan S
- Sneden A
- Branfman A
- Howie G
- Rebhun L
- McIvor W
- Wang R
- Schnaitman T
- Publication year
- Publication venue
- Journal of medicinal chemistry
External Links
Snippet
In an effort to determine the structural requirements for the significant antileukemic, cytotoxic, antitubulin, and antimitotic activity exhibitedby the novel ansa macrolide, maytansine (1), four new C-3 ester and six new C-9 ether homologues were synthesized. The biological …
- 230000000719 anti-leukaemic 0 title abstract description 18
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kupchan et al. | Tumor inhibitors. 124. Structural requirements for antileukemic activity among the naturally occurring and semisynthetic maytansinoids | |
| Kupchan et al. | Tumor inhibitors. 122. The maytansinoids. Isolation, structural elucidation, and chemical interrelation of novel ansa macrolides | |
| US5620985A (en) | Antimitotic binary alkaloid derivatives from catharanthus roseus | |
| Arcamone et al. | Synthesis and antitumour activity of new daunorubicin and adriamycin analogues | |
| US4729996A (en) | Antitumor compositions and their methods of use | |
| Kupchan et al. | Tumor inhibitors. 117. The isolation and structural elucidation of new potent antileukemic diterpenoid esters from Gnidia species | |
| Magri et al. | Modified taxols. 2. Oxidation products of taxol | |
| EP0074770A1 (en) | Camptothecin-1-oxide derivatives, process for preparing same, formulations comprising said derivatives and said derivatives for use in producing an anti-tumour effect | |
| CA2067491A1 (en) | Camptothecin analogs as potent inhibitors of human colorectal cancer | |
| US5401747A (en) | Alkyl camptothecin compounds as potent inhibitors of human colorectal cancer | |
| Kupchan et al. | Structural requirements for biological activity among antileukemic glaucarubolone ester quassinoids | |
| DE69726007T2 (en) | PRODROGS AND ANALOGA OF CAMPTOTHECIN AND THE USE THEREOF AS MEDICINAL PRODUCTS | |
| CA1060003A (en) | N-trifluoroacetyladriamycin-14-alkanoates and therapeutic compositions containing same | |
| EP0018231A2 (en) | A process for the preparation of bis-indole-alkaloids and acid addition salts thereof and new bis-indole-alkaloids, pharmaceutical compositions containing them and their use as antitumour agents | |
| IL96643A (en) | Chiral 3'-deamino-3'-(2"(S)-methoxy-4"-morpholinyl)-doxorubicin, its preparation and pharmaceutical compositions containing it | |
| US4826964A (en) | Bridged oxygen analogs of daunorubcin and doxorubicin | |
| US3872091A (en) | New 2{62 , 16{62 -diamino-androstanes and their preparation | |
| HU216844B (en) | Alkaloides from mappia foetida and process for their production, pharmaceutical compositions containing them | |
| Murakoshi et al. | (−)-3β-13α-dihydroxylupanine from cytisus scoparius | |
| DE60000328T2 (en) | Camptothecin Analogous compounds, process for their preparation and pharmaceutical compositions containing them | |
| JP2003503503A (en) | Novel xanthone compounds, their production and use as medicaments | |
| DE69819340T2 (en) | OPTICALLY PURE CAMPTOTHECIN ANALOG, OPTICALLY PURE SYNTHESIS INTERMEDIATE AND METHOD FOR THE PRODUCTION THEREOF | |
| Shoeb et al. | Alangiside, the monoterpenoid alkaloidal glycoside from Alangium lamarckii Thw. | |
| US4895852A (en) | Antitumor alkaloids | |
| US4279916A (en) | Method of treatment using new leurosine derivatives |